...
首页> 外文期刊>ANZ journal of surgery >Safety and efficacy of trisectionectomy for hepatocellular carcinoma
【24h】

Safety and efficacy of trisectionectomy for hepatocellular carcinoma

机译:三部分切除术治疗肝细胞癌的安全性和有效性

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Right or left trisectionectomy represents the most extensive and difficult type of hepatic resection, and carries an unfavourably high morbidity and mortality. This retrospective study aimed to evaluate the safety and efficacy of trisectionectomy for hepatocellular carcinoma (HCC).Methods: From January 2000 to December 2008, 35 patients with HCC were treated with trisectionectomy. The treatment outcomes of these patients were retrospectively analysed.Results: Twenty-three right and 12 left trisectionectomies were performed. The overall operative morbidity and mortality were 42.8% (n = 15) and 2.8% (n = 1), respectively. The 1-, 3-, and 5-year overall survival rates were 82.9%, 51.4% and 23.8%, while the 1-, 3- and 5-year disease-free survival rates were 71.4%, 42.9% and 12.9%, respectively.Conclusions: With careful patient selection and meticulous surgical technique, trisectionectomy can be performed safely and is associated with long-term survival in a subset of patients with HCC.
机译:背景:右或左三叶切除术是最广泛,最困难的肝切除术,其发病率和死亡率都很高。这项回顾性研究旨在评估三部分切除术治疗肝细胞癌(HCC)的安全性和有效性。方法:从2000年1月至2008年12月,对35例HCC患者进行了三部分切除术治疗。回顾性分析这些患者的治疗结果。结果:进行了23例左三切和12例左三切。总体手术发病率和死亡率分别为42.8%(n = 15)和2.8%(n = 1)。 1年,3年和5年总生存率分别为82.9%,51.4%和23.8%,而1年,3年和5年无病生存率分别为71.4%,42.9%和12.9%,结论:通过仔细的患者选择和精心的外科手术技术,三部分切除术可以安全地进行,并与部分肝癌患者的长期生存相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号